Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Hall

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Oncology Research and Treatment|August 11, 2017
Heterogeneity of Outcomes in D'Amico Intermediate-Risk Prostate Cancer Patients after Radical Prostatectomy: Influence of Primary and Secondary Gleason ScoreMatthew E Pollard, Adele R Hobbs, Young Suk Kwon, et al.
World Journal of Urology|May 25, 2012
Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United StatesAlexander C Small, Che-Kai Tsao, Erin L Moshier, et al.
Psycho-Oncology|April 15, 2021
Improved cancer coping from a web-based intervention for prostate cancer survivors: A randomized controlled trialErin K Tagai, Suzanne M Miller, Shawna V Hudson, et al.
Urology|August 26, 2021
Feasibility and Utility of Mobile Applications for the Evaluation of Urology Residents' Surgical CompetenceDaniel Nethala, Clay Martin, Luke Griffiths, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancerTomasz M Beer, Guy T Bernstein, John M Corman, et al.
Clinical Genitourinary Cancer|June 2, 2012
Trends in the use of cytoreductive nephrectomy in the United StatesChe-Kai Tsao, Alexander C Small, Erin L Moshier, et al.
Journal of Medical Internet Research|October 20, 2023
Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of HealiumMichael A Diefenbach, Allison Marziliano, Erin K Tagai, et al.
The Journal of Clinical Investigation|July 4, 2008
KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasisGoutham Narla, Analisa DiFeo, Yolanda Fernandez, et al.
The Journal of Urology|March 10, 2017
Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3aParas H Shah, Daniel M Moreira, Vinay R Patel, et al.
World Journal of Urology|December 11, 2012
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysisChe-kai Tsao, Alexander C Small, Max Kates, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Oncology Research and Treatment|August 11, 2017
Heterogeneity of Outcomes in D'Amico Intermediate-Risk Prostate Cancer Patients after Radical Prostatectomy: Influence of Primary and Secondary Gleason ScoreMatthew E Pollard, Adele R Hobbs, Young Suk Kwon, et al.
World Journal of Urology|May 25, 2012
Trends and variations in utilization of nephron-sparing procedures for stage I kidney cancer in the United StatesAlexander C Small, Che-Kai Tsao, Erin L Moshier, et al.
Psycho-Oncology|April 15, 2021
Improved cancer coping from a web-based intervention for prostate cancer survivors: A randomized controlled trialErin K Tagai, Suzanne M Miller, Shawna V Hudson, et al.
Urology|August 26, 2021
Feasibility and Utility of Mobile Applications for the Evaluation of Urology Residents' Surgical CompetenceDaniel Nethala, Clay Martin, Luke Griffiths, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Randomized trial of autologous cellular immunotherapy with sipuleucel-T in androgen-dependent prostate cancerTomasz M Beer, Guy T Bernstein, John M Corman, et al.
Clinical Genitourinary Cancer|June 2, 2012
Trends in the use of cytoreductive nephrectomy in the United StatesChe-Kai Tsao, Alexander C Small, Erin L Moshier, et al.
Journal of Medical Internet Research|October 20, 2023
Preference Elicitation and Treatment Decision-Making Among Men Diagnosed With Prostate Cancer: Randomized Controlled Trial Results of HealiumMichael A Diefenbach, Allison Marziliano, Erin K Tagai, et al.
The Journal of Clinical Investigation|July 4, 2008
KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasisGoutham Narla, Analisa DiFeo, Yolanda Fernandez, et al.
The Journal of Urology|March 10, 2017
Partial Nephrectomy is Associated with Higher Risk of Relapse Compared with Radical Nephrectomy for Clinical Stage T1 Renal Cell Carcinoma Pathologically Up Staged to T3aParas H Shah, Daniel M Moreira, Vinay R Patel, et al.
World Journal of Urology|December 11, 2012
Cytoreductive nephrectomy for metastatic renal cell carcinoma in the era of targeted therapy in the United States: a SEER analysisChe-kai Tsao, Alexander C Small, Max Kates, et al.
Pageof 6